Light to moderate levels of lifetime drinking may increase the overall cancer risk with a dose‐response association, and the overall cancer risk appears to be lowest with zero alcohol consumption in …
In the biomedical field, including in geriatric oncology, many papers study the association of a factor X with an outcome Y, usually adjusted on several…
PURPOSEIn patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), brentuximab vedotin (BV) as monotherapy or combined with either lenalidomide (Len) or rituximab…
Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer with residual invasive disease after neoadjuvant systemic therapy have a high risk of…
Background Microscopic colitis (MC) is an inflammatory disorder of the colon. To date, the relationship between inflammatory eye diseases and MC is unclear. Objective To…
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
The Latest in Oncology delivered weekly to your inbox, a simple click and you are set to go!
This multicenter cohort study develops and assesses the validity of a deep learning model for predicting immune checkpoint inhibitor response in patients with advanced non−small…
A diagnosis of prostate cancer (PC) is a life-changing event that often prompts asymptomatic men to opt for local treatment. The cancer control afforded by…
Reirradiation of brain tumors has a long history of preclinical and clinical studies especially with regards to effectiveness and safety in the recurrent setting. Clinical…
